Skip to main content
. 2021 Dec 17;12:762242. doi: 10.3389/fphys.2021.762242

Figure 8.

Figure 8

Distribution of metabolic dysfunction in MAFLD patients among different quartiles of monocyte to HDL cholesterol ratio (MHR). Metabolic dysfunction indicators: waist circumference (WC) ≥ 90 cm for men and ≥ 80 cm for women; systolic blood pressure (SBP) ≥ 130 mmHg or diastolic blood pressure (DBP) ≥85 mmHg or treatment of previously diagnosed hypertension; TG levels ≥ 1.70 mmol/L or specific treatment for this lipid abnormalities; high-density lipoprotein cholesterol levels (HDL-c) of < 1.0 mmol/L in men and < 1.3 mmol/L in women or specific treatment for this lipid abnormalities; fasting plasma glucose (FPG) of ≥ 5.60 mmol/L or previously diagnosed T2DM; uric acid (UA) levels of ≥420 μmol/L or specific treatment for this abnormalities; urinary microalbumin (uMA) > 30 mg/L or MA/UCREA > 30 mg/L.